Volume 117, Issue 1 , Pages 204-211, January 2006
Pulmonary TH2 response in Pseudomonas aeruginosa–infected patients with cystic fibrosis
Background
Pseudomonas aeruginosa infection determines the course of cystic fibrosis (CF) lung disease. Studies in human peripheral blood indicate that P aeruginosa infection is associated with a predominant TH2 immune response, whereas TH1 responses are accompanied by a better pulmonary outcome.
Objective
Analyses of peripheral blood may not correspond directly with the local pulmonary immune response. Therefore, we asked whether the TH1/TH2 response is altered in bronchoalveolar lavage fluid from P aeruginosa–infected patients with CF.
Methods
Bronchoalveolar lavage fluid was obtained from 12 patients with CF chronically infected with P aeruginosa, 11 noninfected patients with CF, and 8 healthy controls. Pulmonary CXCR3+ (TH1) and CCR4+ (TH2) expressing CD4+ and CD8+ lymphocytes were quantified by flow cytometry. Levels of TH1-associated (IL-2, IFN-γ, IFN-γ inducible T cell-α chemoattractant, Monokine induced by IFN-γ, IFN-γ inducible protein of 10 kd) and TH2-associated (IL-4, IL-5, IL-10, thymus and activation-regulated chemokine [TARC], macrophage-derived chemokine) cytokines and chemokines and a panel of proinflammatory molecules were quantified at the protein level. Chemokines mRNA levels were assessed by real time RT-PCR.
Results
P aeruginosa–infected patients with CF had significantly higher levels of pulmonary CCR4+CD4+ (TH2) cells, IL-4, IL-13, and TARC and lower levels of IFN-γ compared with noninfected patients with CF and healthy controls. Bronchoalveolar lavage fluid levels of IL-4, IL-13, and TARC correlated inversely with FEV1 in P aeruginosa–infected patients with CF.
Conclusion
These results reveal the prevalence of a pulmonary TH2 immune response in P aeruginosa–infected patients with CF. The modulation of the pulmonary TH2 response in P aeruginosa infection may be an option for the treatment of P aeruginosa lung disease in patients with CF.
Key words: Cystic fibrosis, Pseudomonas aeruginosa, bronchoalveolar lavage fluid, TARC, MDC, CCR4, TH1/TH2, cytokines
Abbreviations used: BAL, Bronchoalveolar lavage, BALF, Bronchoalveolar lavage fluid, CF, Cystic fibrosis, G-CSF, Granulocyte colony-stimulating factor, IP-10, IFN-γ inducible protein of 10 kd, ITAC, IFN-γ inducible T cell-α chemoattractant, MCP, Macrophage chemotactic protein, MDC, Macrophage-derived chemokine, Mig, Monokine induced by IFN-γ, MIP, Macrophage inflammatory protein, OdDHL, N-(3-oxododecanoyl)-homoserine lactone, TARC, Thymus and activation-regulated chemokine, Tc, T cytotoxic cell type
Supported by grants from the Else-Kröner-Fresenius Stiftung, the Friedrich-Baur-Stiftung, the University and Science Program of the Ludwig-Maximilians-University (HWP), and the Clinical Cooperation Groups Pediatric Immune Regulation and Immune Monitoring.
PII: S0091-6749(05)02109-3
doi:10.1016/j.jaci.2005.09.023
© 2005 American Academy of Allergy, Asthma and Immunology. Published by Elsevier Inc. All rights reserved.
Volume 117, Issue 1 , Pages 204-211, January 2006
